Patents Assigned to MICHAEL KENYON
  • Publication number: 20140296192
    Abstract: The invention relates to a pharmaceutical composition of unit dose for inhalation by a human subject comprising a topical corticoid and a quinolone or fucidic acid, characterized in that the ratio of the weight of the topical corticoid to the weight of the quinolone or fucidic acid is between 0.02 and 20 and the amount of quinolone or of fucidic acid is less than 1 mg. This composition can be administered by nasal spray and is used for treating the upper and lower respiratory tract, in particular sinusitis and nasal polyps.
    Type: Application
    Filed: March 19, 2012
    Publication date: October 2, 2014
    Applicants: MATTHEW KRAYENBUHL, MICHAEL KENYON, ANTONIO DOS SANTOS
    Inventor: Matthew Krayenbuhl